127 related articles for article (PubMed ID: 38519779)
1. Development of Epigallocatechin 3-gallate-Loaded Hydrogel Nanocomposites for Oral Submucous Fibrosis.
Mehta CH; Velagacherla V; Manandhar S; Nayak Y; Pai SRK; Acharya S; Nayak UY
AAPS PharmSciTech; 2024 Mar; 25(4):66. PubMed ID: 38519779
[TBL] [Abstract][Full Text] [Related]
2. Polyphenol-based targeted therapy for oral submucous fibrosis.
Mehta CH; Paliwal S; Muttigi MS; Seetharam RN; Prasad ASB; Nayak Y; Acharya S; Nayak UY
Inflammopharmacology; 2023 Oct; 31(5):2349-2368. PubMed ID: 37106237
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
Hsieh YP; Chen HM; Lin HY; Yang H; Chang JZ
J Formos Med Assoc; 2017 Feb; 116(2):107-113. PubMed ID: 26922429
[TBL] [Abstract][Full Text] [Related]
4. A biomaterial-based therapy using a sodium hyaluronate/bioglass composite hydrogel for the treatment of oral submucous fibrosis.
Guo ZX; Zhang Z; Yan JF; Xu HQ; Wang SY; Ye T; Han XX; Wang WR; Wang Y; Gao JL; Niu LN; Chang J; Jiao K
Acta Biomater; 2023 Feb; 157():639-654. PubMed ID: 36509401
[TBL] [Abstract][Full Text] [Related]
5. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transforming growth factor beta1 gene in oral submucous fibrosis induced in Sprague-Dawley rats by injections of areca nut and pan masala (commercial areca nut product) extracts.
Maria S; Kamath VV; Satelur K; Rajkumar K
J Cancer Res Ther; 2016; 12(1):379-85. PubMed ID: 27072267
[TBL] [Abstract][Full Text] [Related]
7. Activation of transforming growth factor-β1 by thrombin via integrins αvβ1, αvβ3, and αvβ5 in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Chang JZ; Hsieh YP; Lin WH; Chen HM; Kuo MY
Head Neck; 2017 Jul; 39(7):1436-1445. PubMed ID: 28464379
[TBL] [Abstract][Full Text] [Related]
8. Arecoline stimulated early growth response-1 production in human buccal fibroblasts: suppression by epigallocatechin-3-gallate.
Hsieh YP; Chen HM; Chang JZ; Chiang CP; Deng YT; Kuo MY
Head Neck; 2015 Apr; 37(4):493-7. PubMed ID: 24436257
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate stimulated connective tissue growth factor expression in human buccal fibroblasts: Inhibition by epigallocatechin-3-gallate.
Sar JI; Yang CJ; Tsai YS; Deng YT; Chen HM; Chang HH; Liu CM
J Formos Med Assoc; 2015 Sep; 114(9):860-4. PubMed ID: 24035571
[TBL] [Abstract][Full Text] [Related]
10. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro.
Dai JP; Chen XX; Zhu DX; Wan QY; Chen C; Wang GF; Li WZ; Li KS
J Oral Pathol Med; 2014 Jul; 43(6):464-70. PubMed ID: 24484214
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
Huang J; Zhang H; Fan X; Guo J
Oral Health Prev Dent; 2022 Jun; 20(1):339-348. PubMed ID: 35920886
[TBL] [Abstract][Full Text] [Related]
13. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
[TBL] [Abstract][Full Text] [Related]
14. EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
Chang JZ; Yang WH; Deng YT; Chen HM; Kuo MY
Clin Oral Investig; 2013 Mar; 17(2):455-61. PubMed ID: 22415218
[TBL] [Abstract][Full Text] [Related]
15. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
16. [Changes of cytokines secreted by human oral mucosa keratinocytes from oral submucous fibrosis in vitro].
Feng Y; Ling T
Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Feb; 18(1):23-5. PubMed ID: 12539356
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-stimulated connective tissue growth factor (CTGF/CCN2) production in human buccal mucosal fibroblasts: Inhibition by epigallocatechin-3-gallate.
Chang JZ; Yang WH; Deng YT; Chen HM; Kuo MY
Head Neck; 2012 Aug; 34(8):1089-94. PubMed ID: 21953860
[TBL] [Abstract][Full Text] [Related]
18. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits arecoline-induced oral fibrogenesis through transforming growth factor-β/Smad2/3 signaling inhibition.
Chen PY; Ho DC; Liao YW; Hsieh PL; Lu KH; Tsai LL; Su SH; Yu CC
J Formos Med Assoc; 2021 Nov; 120(11):1988-1993. PubMed ID: 33980461
[TBL] [Abstract][Full Text] [Related]
20. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.
Shen YW; Shih YH; Fuh LJ; Shieh TM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
